Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target
Authors
Keywords
Drug resistance, Metastasis, Cancer stem cells, Epithelial-to-mesenchymal transition, Cancer inflammation, Metabolic reprogramming, Nuclear transcription factor-kappa B
Journal
AMINO ACIDS
Volume 49, Issue 3, Pages 425-439
Publisher
Springer Nature
Online
2016-08-25
DOI
10.1007/s00726-016-2320-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability
- (2016) Garima Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Precision oncology: origins, optimism, and potential
- (2016) Vinay Prasad et al. LANCET ONCOLOGY
- Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death
- (2016) H Tatsukawa et al. Cell Death & Disease
- Physiological, pathological, and structural implications of non-enzymatic protein–protein interactions of the multifunctional human transglutaminase 2
- (2015) Kajal Kanchan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
- (2015) Eduard Badarau et al. CHEMISTRY & BIOLOGY
- Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression
- (2015) J. Lee et al. CLINICAL CANCER RESEARCH
- Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation
- (2015) Shiuan-Shinn Lee et al. Clinical Oral Investigations
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival
- (2015) M. L. Fisher et al. MOLECULAR CANCER RESEARCH
- Transglutaminase is a tumor cell and cancer stem cell survival factor
- (2015) Richard L. Eckert et al. MOLECULAR CARCINOGENESIS
- CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer
- (2015) B Min et al. ONCOGENE
- A multi-targeted approach to suppress tumor-promoting inflammation
- (2015) Abbas K. Samadi et al. SEMINARS IN CANCER BIOLOGY
- Designing a broad-spectrum integrative approach for cancer prevention and treatment
- (2015) Keith I. Block et al. SEMINARS IN CANCER BIOLOGY
- Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer
- (2015) Ehsan Malek et al. Oncotarget
- Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells
- (2014) Bo Mi Ku et al. AMINO ACIDS
- An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial–mesenchymal transition and cancer stem cell expansion in human breast cancer cells
- (2014) Lin Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states
- (2014) Mauro Piacentini et al. CELL AND TISSUE RESEARCH
- Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor
- (2014) Amy Lee Han et al. EUROPEAN JOURNAL OF CANCER
- A Novel Mechanism by Which Tissue Transglutaminase Activates Signaling Events That Promote Cell Survival
- (2014) Lindsey K. Boroughs et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models
- (2014) Bo Mi Ku et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas
- (2014) Deborah T. Leicht et al. Journal of Thoracic Oncology
- Simultaneously Targeting Tissue Transglutaminase and Kidney Type Glutaminase Sensitizes Cancer Cells to Acid Toxicity and Offers New Opportunities for Therapeutic Intervention
- (2014) William P. Katt et al. MOLECULAR PHARMACEUTICS
- Transglutaminase Regulation of Cell Function
- (2014) Richard L. Eckert et al. PHYSIOLOGICAL REVIEWS
- Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
- (2014) Bakhtiyor Yakubov et al. PLoS One
- Regulation of NF-κB by TNF family cytokines
- (2014) Matthew S. Hayden et al. SEMINARS IN IMMUNOLOGY
- The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma
- (2014) Selcuk Erdem et al. WORLD JOURNAL OF UROLOGY
- Tissue transglutaminase: An emerging target for therapy and imaging
- (2013) Markus Pietsch et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways
- (2013) Santosh Kumar et al. INTERNATIONAL JOURNAL OF CANCER
- Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2013) Jae-Heon Jeong et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility
- (2013) Andrew Pierce et al. PROTEOMICS
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis
- (2013) Z Wang et al. Cell Death & Disease
- Metabolic changes in cancer: beyond the Warburg effect
- (2012) W. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins
- (2012) P. Torricelli et al. AMINO ACIDS
- The Thioredoxin System as a Therapeutic Target in Human Health and Disease
- (2012) Dler Faieeq Darweesh Mahmood et al. ANTIOXIDANTS & REDOX SIGNALING
- Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype
- (2012) Kevin D. Brown BREAST CANCER RESEARCH AND TREATMENT
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Tissue Transglutaminase Constitutively Activates HIF-1α Promoter and Nuclear Factor-κB via a Non-Canonical Pathway
- (2012) Santosh Kumar et al. PLoS One
- Regulation of the activities of the mammalian transglutaminase family of enzymes
- (2012) Cornelius Klöck et al. PROTEIN SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- New insights into the functions and localization of nuclear transglutaminase 2
- (2011) Ting-Fang Kuo et al. FEBS Journal
- Extracellular TG2: emerging functions and regulation
- (2011) Alexey M. Belkin FEBS Journal
- Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling
- (2011) Zsolt Sarang et al. IMMUNOLOGY LETTERS
- Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
- (2011) Han-Shui Hsu et al. LUNG CANCER
- Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
- (2011) L Cao et al. ONCOGENE
- Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes
- (2011) Evgeny A. Zemskov et al. PLoS One
- Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells
- (2011) Anupam Kumar et al. PLoS One
- Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions
- (2011) Zhuo-Xin Cheng et al. PLoS One
- TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2
- (2011) M. Delhase et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
- (2011) Kapil Mehta et al. Cancers
- Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells
- (2010) Clément Faye et al. BIOCHEMICAL JOURNAL
- Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
- (2010) Kapil Mehta et al. BIOCHEMICAL PHARMACOLOGY
- Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia
- (2010) K. Csomos et al. BLOOD
- Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma
- (2010) Tasneem Kausar et al. CANCER INVESTIGATION
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis
- (2010) C. Nadalutti et al. CELL PROLIFERATION
- Characterization of transglutaminase type II role in dendritic cell differentiation and function
- (2010) Ivana Matic et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
- (2010) Chad J. Creighton et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The transglutaminase 2 gene is aberrantly hypermethylated in glioma
- (2010) Lisa M. Dyer et al. JOURNAL OF NEURO-ONCOLOGY
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
- (2010) Anupam Kumar et al. PLoS One
- EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation
- (2010) B. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer
- (2009) Norikatsu Miyoshi et al. ANNALS OF SURGICAL ONCOLOGY
- Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
- (2009) Yadi Wu et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
- (2009) M. Shao et al. CANCER RESEARCH
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors
- (2009) Dae-Seok Kim Frontiers in Bioscience-Landmark
- Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase
- (2009) Evgeny A. Zemskov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- Transglutaminase 2 Is Needed for the Formation of an Efficient Phagocyte Portal in Macrophages Engulfing Apoptotic Cells
- (2009) B. Toth et al. JOURNAL OF IMMUNOLOGY
- Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation
- (2009) Youngmi Kim et al. MOLECULAR IMMUNOLOGY
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor κB expression
- (2009) Ruchi Gupta et al. VIRCHOWS ARCHIV
- Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer
- (2008) K. Mehta AMINO ACIDS
- Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
- (2008) J. Y. Hwang et al. CANCER RESEARCH
- The transglutaminase 2 gene ( TGM2 ), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer
- (2008) Lingbao Ai et al. CARCINOGENESIS
- Tissue Transglutaminase Regulates Focal Adhesion Kinase/AKT Activation by Modulating PTEN Expression in Pancreatic Cancer Cells
- (2008) A. Verma et al. CLINICAL CANCER RESEARCH
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
- (2008) Jordi Rius et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
- (2008) A Jeanes et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started